BRONCHIAL ASTHMA CLINICAL SIGNS AND PREVENTIONAuthors
Keywords:
cientific overview of bronchial asthma, iology, immunopathogenesis, clinical manifestations, diagnostic methods, and modern treatment approachesAbstract
This monograph presents a comprehensive scientific overview of bronchial asthma as one of the most prevalent chronic inflammatory diseases of the respiratory system. It covers the etiology, immunopathogenesis, clinical manifestations, diagnostic methods, and modern treatment approaches, emphasizing both theoretical analysis and clinical application.
Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation and reversible airflow obstruction, manifesting as episodes of wheezing, shortness of breath, chest tightness, and coughing. The monograph explores the immunological and environmental triggers, the classification of asthma severity, and criteria for differential diagnosis. It also outlines diagnostic procedures such as spirometry, peak flow monitoring, and allergen testing.
The treatment section addresses current pharmacological therapies, including inhaled corticosteroids, beta-agonists, and leukotriene modifiers, alongside non-pharmacological strategies such as respiratory training, environmental control, patient education, and psychological support. Special attention is given to preventive strategies aimed at reducing exacerbations and improving long-term disease management through patient self-awareness and lifestyle modifications.
This monograph is intended for medical professionals, clinical researchers, academic faculty, and medical students seeking a detailed resource on the clinical and preventive aspects of bronchial asthma.
References
Global Initiative for Asthma (GINA). (2023). Global strategy for asthma management and prevention. Retrieved from https://ginasthma.org
National Heart, Lung, and Blood Institute (NHLBI). (2020). Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. U.S. Department of Health and Human Services.
Wenzel, S. E. (2012). Asthma phenotypes: The evolution from clinical to molecular approaches. Nature Medicine, 18(5), 716–725. https://doi.org/10.1038/nm.2678
Holgate, S. T. (2008). Pathogenesis of asthma. Clinical & Experimental Allergy, 38(6), 872–897. https://doi.org/10.1111/j.1365-2222.2008.03071.x
Martinez, F. D. (2009). The origins of asthma and chronic obstructive pulmonary disease in early life. Proceedings of the American Thoracic Society, 6(3), 272–277. https://doi.org/10.1513/pats.200808-090RM
Bateman, E. D., Bousquet, J., Keech, M. L., Busse, W. W., Clark, T. J. H., Pedersen, S. E., & Thompson, P. J. (2008). Overall asthma control: The relationship between current control and future risk. Journal of Allergy and Clinical Immunology, 125(3), 600–608. https://doi.org/10.1016/j.jaci.2009.10.007
Bousquet, J., Anto, J. M., Bachert, C., et al. (2010). Prevention of asthma: What are the possibilities? European Respiratory Journal, 36(5), 1172–1187. https://doi.org/10.1183/09031936.00053710
Beasley, R., Semprini, A., & Mitchell, E. A. (2015). Risk factors for asthma: Is prevention possible? The Lancet, 386(9998), 1075–1085. https://doi.org/10.1016/S0140-6736(15)00156-7
Boulet, L. P., Boulay, M. É., Gagnon, S., et al. (2012). Benefits of an asthma education program on asthma control and quality of life. Canadian Respiratory Journal, 19(6), 371–376. https://doi.org/10.1155/2012/158545
Pauwels, R. A., Buist, A. S., Calverley, P. M. A., Jenkins, C. R., & Hurd, S. S. (2003). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 163(5), 1256–1276
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Novateur Publication